Noninvasive approach for the management of hemolytic disease of the fetus

Expert Review of Hematology

Volumn 2, Issue 5, 2009, Pages 577-582

  Illanes, Sebastian ^a   Soothill, Peter ^b  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

Cell free fetal DNA; Doppler of middle cerebral artery; Fetal genotype; Intrauterine transfusion

Indexed keywords

ALLOANTIBODY; DNA; MATERNAL ANTIBODY; RHESUS D ANTIBODY;

BLOOD GROUP RH; DOPPLER ECHOGRAPHY; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FOLLOW UP; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

BLOOD TRANSFUSION, INTRAUTERINE; ERYTHROBLASTOSIS, FETAL; FEMALE; GENOTYPE; HUMANS; RH-HR BLOOD-GROUP SYSTEM; ULTRASONOGRAPHY, PRENATAL;

EID: 77953431764     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.09.45     Document Type: Review

References (51)

1. Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang. 78(Suppl. 2), 155-162 (2000).
2. Le van Kim C, Mouro I, Chérif-Zahar B et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc. Natl Acad. Sci. USA 89(22), 10925-10929 (1992).
3. Bennett PR, Le van Kim C, Colin Y et al. Prenatal determination of fetal RhD type by DNA amplification. N. Engl. J. Med. 329(9), 607-610 (1993).
4. Wolter LC, Hyland CA, Saul A. Rhesus D genotyping using polymerase chain reaction. Blood 82(5), 1682-1683 (1993).
5. Finning KM, Martin PG, Soothill PW, Avent NW. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42, 1079-1085 (2002).
6. Nanal R, Kyle P, Soothill PW. A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix. Prenat. Diagn. 23(6), 488-492 (2003).
7. Tabor A, Bang J, Nørgaard-Pedersen B. Feto-maternal haemorrhage associated with genetic amniocentesis: results of a randomized trial. Br. J. Obstet. Gynecol. 94, 528-534 (1987).
8. Murray JC, Karp LE, Williamson RA, Cheng EY, Luthy DA. Rh isoimmunization related to amniocentesis. Am. J. Med. Genet. 16, 527-534 (1983).
9. Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487 (1997).
10. Illanes S, Avent N, Soothill PW. Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound. Ultrasound Obstet. Gynecol. 25(4), 317-322 (2005).
11. Illanes S, Denbow M, Kailasam C, Finning K, Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum. Dev. 83(9), 563-566 (2007).
12. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am. J. Pathol. 169(2), 400-404 (2006).
13. Alberry MS, Maddocks DG, Hadi MA et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am. J. Obstet. Gynecol. 200(1), 98.E1-E6 (2009).
14. Lo YMD. Fetal RhD genotyping from maternal plasma. Ann. Med. 31, 308-312 (1999).
15. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am. J. Obstet. Gynecol. 195(4), 1163-1173 (2006).
16. Chitty LS, van der Schoot CE, Hahn S, Avent ND. SAFE - the Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements. Prenat. Diagn. 28, 83-88 (2008).
17. Legler TJ, Liu Z, Mavrou A, Finning KM et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat. Diagn. 27, 824-829 (2007).
18. Müller SP, Bartels I, Stein W et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 48(11), 2292-2301 (2008).
19. Li Y, Finning K, Daniels G, Hahn S, Zhong X, Holzgreve W. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry. Prenat. Diagn. 28(3), 203-208 (2008).
20. Van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus. Med. Rev. 17, 31-44 (2003).
21. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 47(11), 2126-2133 (2007).
22. Geifman-Holtzman O, Grotegut CA, Gaughan JP, Holtzman EJ, Floro C, Hernandez E. Noninvasive fetal RhCE genotyping from maternal blood. BJOG 116(2), 144-151 (2009).
23. Soothill PW, Nicolaides KH, Rodeck CH, Clewell WH, Lindridge J. Relationship of fetal hemoglobin and oxygen content to lactate concentration in Rh isoimmunized pregnancies. Obstet. Gynecol. 69, 268-271 (1987).
24. Nicolaides KH, Warenski JC, Rodeck CH. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. Am. J. Obstet. Gynecol. 152, 341-344 (1985).
25. Bowman JM. The management of Rh isoimmunization. Obstet. Gynecol. 52, 1-16 (1978).
26. Socol ML, MacGregor SN, Pielet BW, Tamura RK, Sabbagha RE. Percutaneous umbilical transfusion in severe rhesus isoimmunization: resolution of fetal hydrops. Am. J. Obstet. Gynecol. 157, 1369-1375 (1987).
27. Nicolaides KH, Soothill PW, Clewell WH, Rodeck CH, Mibashan RS, Campbell S. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1, 1073-1075 (1988).
28. Queenan JT. Current management of the Rh-sensitized patient. Clin. Obstet. Gynecol. 25, 293-301 (1982).
29. De Vore GR, Mayden K, Tortora M, Berkowitz RL, Hobbins JC. Dilation of the fetal umbilical vein in rhesus haemolytic anemia: a predictor of severe disease. Am. J. Obstet. Gynecol. 141, 464-466 (1981).
30. Nicolaides KH, Fontanarosa M, Gabbe SG, Rodeck CH. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunisation. Am. J. Obstet. Gynecol. 158, 920-926 (1988).
31. Bahado-Singh R, Oz U, Mari G, Jones D, Paidas M, Onderoglu L. Fetal splenic size in anemia due to Rh-alloimmunization. Obstet. Gynecol. 92(5), 828-832 (1998).
32. Vintzileos AM, Campbell WA, Storlazzi E, Mirochnick MH, Escoto DT, Nochimson DJ. Fetal liver ultrasound measurements in isoimmunized pregnancies. Obstet. Gynecol. 68(2), 162-167 (1986).
33. Roberts AB, Mitchell JM, Pattison NS. Fetal liver length in normal and isoimmunized pregnancies. Am. J. Obstet. Gynecol. 161(1), 42-46 (1989).
34. Rightmire DA, Nicolaides KH, Rodeck CH, Campbell S. Fetal blood velocities in Rh isoimmunization: relationship to gestational age and to fetal hematocrit. Obstet. Gynecol. 68(2), 233-236 (1986). (Pubitemid 16038623)
35. Hecher K, Snijders R, Campbell S, Nicolaides K. Fetal venous, arterial, and intracardiac blood flows in red blood cell isoimmunisation. Obstet. Gynecol. 85, 122-128 (1995).
36. Oepkes D, Brand R, Vandenbussche FP, Meerman RH, Kanhai HHH. The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: a multivariate analysis. Br. J. Obstet. Gynaecol. 101, 680-684 (1994).
37. Steiner H, Schaffer H, Spitzer D, Batka M, Graf AH, Staudach A. The relationship between peak velocity in the fetal descending aorta and hematocrit in rhesus isoimmunization. Obstet. Gynecol. 85(Pt 1), 659-662 (1995).
38. Vyas S, Nicolaides KH, Campbell S. Doppler examination of the middle cerebral artery in anemic fetuses. Am. J. Obstet. Gynecol. 162, 1066-1068 (1990).
39. Mari G, Adrignolo A, Abuhamad AZ, et al. Diagnosis of fetal anemia with Doppler ultrasound in the pregnancy complicated by maternal blood group immunization. Ultrasound Obstet. Gynecol. 5(6), 400-405 (1995).
40. Mari G, Rahman F, Olofsson P, Ozcan T, Copel JA. Increase of fetal hematocrit decreases the middle cerebral artery peak systolic velocity in pregnancies complicated by rhesus alloimmunization. J. Matern. Fetal Med. 6, 206-208 (1997).
41. Mari G, Deter RL, Carpenter RL et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N. Engl. J. Med. 342, 9-14 (2000). (Pubitemid 30020654)
42. Abdel-Fattah SA, Soothill PW, Carroll SG, Kyle PM. Middle cerebral artery Doppler for the prediction of fetal anaemia in cases without hydrops: a practical approach. Br. J. Radiol. 75(897), 726-730 (2002).
43. Campbell S, Harrington K, Hecher K. The fetal arterial circulation. In: A Colour Atlas of Doppler Ultrasonography in Obstetrics. Harrington K, Campbell S (Eds). Edward Arnold 59-69 (1995).
44. Szczepura A, Bonsel G, Krauth C, Osipenko L, Haverkamp A. Fetal RHD typing: is fetal RHD typing in all RhD negative women cost effective? BMJ 336(7650), 906 (2008).
45. Avent ND. RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol. Biol. 444, 185-201 (2008).
46. Avent ND. Large-scale blood group genotyping: clinical implications. Br. J. Haematol. 144(1), 3-13 (2009).
47. Oepkes D, Seaward PG, Vandenbussche FP et al. DIAMOND Study Group. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N. Engl. J. Med. 355(2), 156-164 (2006).
48. Abdel-Fattah SA, Shefras J, Kyle PM, Cairns P, Hunter A, Soothill PW. Reassuring fetal middle cerebral artery doppler velocimetry in alloimmunised pregnancies: neonatal outcomes without invasive procedures. Fetal Diagn. Ther. 20(5), 341-345 (2005).
49. Bartha JL, Illanes S, Abdel-Fattah S, Hunter A, Denbow M, Soothill PW. Comparison of different reference values of fetal blood flow velocity in the middle cerebral artery for predicting fetal anemia. Ultrasound Obstet. Gynecol. 25(4), 335-340 (2005).
50. Nicolaides KH, Soothill PW, Rodeck CH, Clewell W. Rh disease: intravascular fetal blood transfusion by cordocentesis. Fetal Ther. 1(4), 185-192 (1986).
51. Thein AT, Soothill P. Antenatal invasive therapy. Eur. J. Pediatr. 157(Suppl. 1), S2-S6 (1998).